According to Badrah et al. [37], individuals with DN had no distinction in their serum concentrations of VEGF-A from those without DN; however, those suffering from subclinical DN had far greater levels than those with confirmed DN. The gene discussed is VEGFA; the disease is liver dysplastic nodule.